Statins Reduce Cardiovascular Events in Older Adults, But Not Disability, According to New NEJM Study

New findings from the STAREE trial, simultaneously published in the New England Journal of Medicine, indicate that statin therapy for primary prevention significantly reduces major cardiovascular events in older adults without known cardiovascular disease. However, the study did not show a reduction in disability. These results are crucial for informing updated primary prevention guidance for older adults, as previous statin trials primarily focused on individuals up to age 75.